Actinium-225 in Targeted Alpha-Particle Therapeutic Applications

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 4, 2011-10 ,pp. : 306-320

Bentham Science Publishers

Access to resources Recommend Favorite

An Overview of Targeted Alpha Therapy with ²²⁵Actinium and ²¹³Bismuth

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 200-208

Bentham Science Publishers

Access to resources Recommend Favorite

The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications

By  

Current Radiopharmaceuticals, Vol. 11, Iss. 3, 2018-12 ,pp. : 154-155

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha-particle radioimmunotherapy with astatine-211 and bismuth-213

By Lucignani Giovanni  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Iss. 9, 2008-09 ,pp. : 1729-1733

Springer Publishing Company

Access to resources Recommend Favorite

Separation of the alpha-emitting radioisotopes actinium-225 and bismuth-213 from thorium-229 using alpha recoil methods

By Ruddy F.H.   Dulloo A.R.   Seidel J.G.   Petrovic B.  

Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, Vol. 213, Iss. unknown, 2004-01 ,pp. : 351-356

Elsevier

Access to resources Recommend Favorite